Profile picture for user humphreys.keith

Keith Humphreys

Esther Ting Memorial Professor of Psychiatry and Behavioral Sciences, Stanford University
Chapter Member: Bay Area SSN, California SSN
Areas of Expertise:
  • Mental Health
  • Food & Drug Regulation

About Keith

Humphreys' research addresses the prevention and treatment of addictive disorders, the formation of public policy and the extent to which subjects in medical research differ from patients seen in everyday clinical practice. For his work in the multinational humanitarian effort to rebuild the psychiatric care system of Iraq and in the national redesign of the VA health system's mental health services for Iraq war veterans, he won the 2009 American Psychological Association Award for Distinguished Contribution to the Public Interest. He and the authors of "Drug Policy and the Public Good" won the 2010 British Medical Association's Award for Public Health Book of the Year.

Humphreys has been extensively involved in the formation of public policy, having served as a member of the White House Commission on Drug Free Communities, the VA National Mental Health Task Force, and the National Advisory Council of the U.S. Substance Abuse and Mental Health Services Administration. During the Obama Administration, he spent a sabbatical year as Senior Policy Advisor at the White House Office of National Drug Control Policy. He has also testified on numerous occasions in Parliament and advises multiple government agencies in the U.K.  

Contributions

How America Can Effectively Fight the Opioid Crisis

In the News

Keith Humphreys quoted on legislation to fight opioid addiction in German Lopez, "Elizabeth Warren’s $100 Billion Plan to Fight the Opioid Epidemic, Explained" Vox, May 8, 2019.
Guest to discuss marijuana drug policies on Vermont Public Radio, Keith Humphreys, April 29, 2019.
"More Older Americans are Smoking Marijuana," Keith Humphreys, Washington Post, April 25, 2018.
Keith Humphreys quoted in Sandhya Raman, "Committees Tackle Politically Powerful Issue of Opioids Legislation" Roll Call, April 25, 2018.
"Does Medical Marijuana Decrease Opioid Use or Boost It?," Keith Humphreys, Washington Post, April 20, 2018.
Keith Humphreys quoted in Olga Khazan, "How France Cut Heroin Overdoses by 79 Percent in 4 Years" The Atlantic, April 16, 2018.
Keith Humphreys's research on German Lopez, "The Maker of OxyContin Tried to Make it Harder to Misuse. It May Have Led to More Heroin Deaths," Vox, April 16, 2018.
Keith Humphreys's research on Pat Oglesby, "Instead of Taxing Opioids, We Can Put the Tax Burden Directly on Opioid Selling," The Hill, April 13, 2018.
"Why Doctors Don't Use Alternatives to Opioids," Keith Humphreys, Washington Post, April 12, 2018.
"There's No Such Thing as an 'Opioid-Addicted' Newborn," Keith Humphreys, Washington Post, April 3, 2018.

Publications

"Brains, Environments, and Policy Responses to Addiction" (with Robert C. Malenka, Brian Knutson, and Robert J. MacCoun). Science 356, no. 6344 (2017): 1237-1238.

Presents policy recommendations to combat opioid addiction.

"The Affordable Care Act Transformation of Substance Use Disorder Treatment" (with Amanda Abraham, Christina Andrews, Colleen Grogan, Thomas D'Aunno, Harold Pollack, and Peter Friedmann). American Journal of Public Health 107, no. 1 (2017): 31-32.

Discusses the impact of the Affordable Care Act on the U.S. response to the opioid epidemic.

"Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States" Annals of Internal Medicine 165, no. 1 (2016): 10-19.

Evaluates the cost-effectiveness and optimal delivery conditions of preexposure prophylaxis for people who inject drugs.

"Drug Policy and the Public Good: Evidence for Effective Interventions" (with John Strang, Thomas Babor, Jonathan Caulkins, Benedikt Fischer, and David Foxcroft). The Lancet 379, no. 9810 (2012): 71-83.

Reviews relevant evidence and outline the likely effects of fuller implementation of existing policy interventions aimed at preventing or reducing the damage that illicit drugs cause to the public good.